Treatment of Pediatric Anxiety Disorders: An Open-Label Extension of the Research Units on Pediatric Psychopharmacology Anxiety Study
The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
BACKGROUND: An 8-week placebo-controlled study, the Research Units on Pediatric Psychopharmacology Anxiety Study, documented beneficial effects of fluvoxamine in the treatment of pediatric social anxiety, separation anxiety, or generalized anxiety disorders. Following completion of this study, participants were invited to enter a 6-month open-label treatment phase designed to examine three issues: (a) long-term maintenance of response in fluvoxamine responders, (b) acute response to fluoxetine in fluvoxamine nonresponders, and (c) acute response to fluvoxamine in placebo nonresponders. METHODS: Participants aged 6-17 years meeting criteria for social anxiety, separation anxiety, or generalized anxiety disorders previously treated in an 8-week placebo-controlled trial (n = 128) were offered open treatment. Changes in symptoms of anxiety during open treatment were assessed in three groups: (a) fluvoxamine responders maintained on fluvoxamine, (b) fluvoxamine nonresponders changed to fluoxetine, and (c) placebo nonresponders changed to fluvoxamine. Response was defined based on Clinical Global Impression criteria. RESULTS: During 6 months of continued open treatment, anxiety symptoms remained low in 33 of 35 (94%) subjects who initially responded to fluvoxamine. Among 14 fluvoxamine nonresponders switched to fluoxetine, anxiety symptoms appeared significantly improved in 10 (71%) subjects. Finally, among 48 placebo nonresponders, 27 (56%) showed clinically significant improvement in anxiety on fluvoxamine. CONCLUSION: The current findings concerning extended treatment of pediatric anxiety disorders are only preliminary, because treatment was uncontrolled. Results suggest that an initial fluvoxamine response is likely to be retained with continued treatment, that some fluvoxamine nonresponders may respond to fluoxetine, and that some placebo nonresponders may respond to fluvoxamine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Children's Global Assessment Scale (CGAS)
Shaffer, D. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790100074010 · Cited by 3,716 · cited 1×
“…Anxiety Rating Scale (PARS; RUPP Anxiety Study Group in press) (Greenhill et al. 1998; Walkup and Davies 1999), clinically significant impairment as assessed with the Children’s Global Assessment Scale (CGAS < 60; Shaffer et al. 1983), and availability of parent and child for weekly visits.”
BIRMAHER, B., KHETARPAL, S., BRENT, D., CULLY, M., BALACH, L., KAUFMAN, J., & NEER, S. M. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199704000-00018 · Cited by 2,846 · cited 3×
“Once per month, they completed the Multidimensional Anxiety Scale for Children (MASC; March et al. 1997) and the Screen for Child Anxiety Related Emotional Disorders (SCARED; Birmaher et al. 1997).”
The Multidimensional Anxiety Scale for Children (MASC): factor structure, reliability, and validity
MARCH, J. S., PARKER, J. D. A., SULLIVAN, K., STALLINGS, P., & CONNERS, C. K. (1997) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199704000-00019 · Cited by 2,236 · cited 4×
“Parents completed the MASC concerning symptoms in the subject (March et al. 1997); both parents and the subject also rated the child on the SCARED (Birmaher et al.”
InfluentialSelf-citationPine, D. S., Cohen, P., Gurley, D., Brook, J., & Ma, Y. (1998) · Archives of General Psychiatry · doi:10.1001/archpsyc.55.1.56 · Cited by 1,753
Self-citationTherapy for youths with anxiety disorders: A second randomized clincal trial.
Kendall, P. C., Flannery-Schroeder, E., Panichelli-Mindel, S. M., Southam-Gerow, M., Henin, A., & Warman, M. (1997) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.65.3.366 · Cited by 984 · cited 1×
“The decision to include participants with any one of the three conditions is consistent with prior treatment studies for any of these disorders, which also include any of the three conditions (Kendall and Southam-Gerow 1996; Kendall et al. 1997).”
Fluvoxamine for the Treatment of Anxiety Disorders in Children and Adolescents
Walkup, J. T., Labellarte, M. J., Riddle, M. A., Pine, D. S., Greenhill, L., Klein, R., Davies, M., Sweeney, M., Abikoff, H., Hack, S., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200104263441703 · Cited by 588
Self-citationCognitive–behavioral treatment of anxiety disorders in children: Long-term (6-year) follow-up.
Barrett, P. M., Duffy, A. L., Dadds, M. R., & Rapee, R. M. (2001) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.69.1.135 · Cited by 414 · cited 1×
“…the data for this follow-up of a placebo-controlled medication trial, follow-up studies from cognitive-behavioral psychotherapy trials suggest that successfully treated anxiety disorders in children may remain in remission for extended periods (Barrett et al. 2001; Kendall and Southam-Gerow 1996).”
PETERSON, B. S., PINE, D. S., COHEN, P., & BROOK, J. S. (2001) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-200106000-00014 · Cited by 335 · cited 1×
“Available longitudinal studies suggest that the childhood anxiety disorders other than OCD may exhibit a somewhat better long-term course than either childhood depression or OCD (Costello et al. 1999; Klein and Pine in press; Peterson et al. 2001; Pine et al. 1998).”
Self-citationImipramine Treatment of Children with Separation Anxiety Disorder
KLEIN, R. G., KOPLEWICZ, H. S., & KANNER, A. (1992) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199201000-00005 · Cited by 201 · cited 1×
“The trial uses an 8-point version of the scale as had been used in prior pediatric psychopharmacology trials (Abikoff and Gittelman 1985; Gittelman-Klein et al. 1976; Graae et al. 1994; Klein et al. 1992).”
Self-citationPine, D. S. (2002) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/104454602760386888 · Cited by 73
Self-citation
Cited by
Garcia, A. M., Sapyta, J. J., Moore, P. S., Freeman, J. B., Franklin, M. E., March, J. S., & Foa, E. B. (2010) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2010.06.013 · Cited by 378
Milham, M. P., Nugent, A. C., Drevets, W. C., Dickstein, D. S., Leibenluft, E., Ernst, M., Charney, D., & Pine, D. S. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.038 · Cited by 186
24- and 36-Week Outcomes for the Child/Adolescent Anxiety Multimodal Study (CAMS)
Piacentini, J., Bennett, S., Compton, S. N., Kendall, P. C., Birmaher, B., Albano, A. M., March, J., Sherrill, J., Sakolsky, D., Ginsburg, G., et al. (2014) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2013.11.010 · Cited by 164
Self-citationAnxiety Disorders in Children and Adolescents
Rockhill, C., Kodish, I., DiBattisto, C., Macias, M., Varley, C., & Ryan, S. (2010) · Current Problems in Pediatric and Adolescent Health Care · doi:10.1016/j.cppeds.2010.02.002 · Cited by 110
Offidani, E., Fava, G. A., Tomba, E., & Baldessarini, R. J. (2013) · Psychotherapy and Psychosomatics · doi:10.1159/000345316 · Cited by 94
Metadata
- Venue
- Journal of Child and Adolescent Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2002-09
- Volume
- 12
- Issue
- 3
- Pages
- 175-188
- ISSN
- 1044-5463 (ISSN-L)
- 1557-8992
- OpenAlex
- W30860161
- Cited by
- 89
- References
- 10
- FWCI
- 8.60
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.